Literature DB >> 3762934

Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis.

P J Dyck, J Karnes, P C O'Brien, C J Swanson.   

Abstract

We developed a true-or-false questionnaire with several hundred questions about symptoms encountered in peripheral neuropathy, to be scored by optical reader and computer. Responses were grouped into scales called "Neuropathy," "Weakness," "Sensory," "Autonomic," and subsets of these. Profiles in health were estimated for each scale based on responses from 300 healthy subjects 15 to 65 years old. The sensitivity and specificity of the scales were tested in patients with motor neuron disease, amyloidosis, or diabetes, with or without neuropathy. The questionnaire was useful in detecting neuropathy and staging severity, and in recognizing patterns that may have diagnostic implications.

Entities:  

Mesh:

Year:  1986        PMID: 3762934     DOI: 10.1212/wnl.36.10.1300

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

1.  Amyloid-like IgM deposition neuropathy: a distinct clinico-pathologic and proteomic profiled disorder.

Authors:  Juan J Figueroa; E Peter Bosch; P James B Dyck; Wolfgang Singer; Julie A Vrana; Jason D Theis; Ahmet Dogan; Christopher J Klein
Journal:  J Peripher Nerv Syst       Date:  2012-06       Impact factor: 3.494

2.  Clinical features predictive of a poor prognosis in acute porphyria.

Authors:  Elena Pischik; Anton Bulyanitsa; Valery Kazakov; Raili Kauppinen
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

3.  Predictive model to identify the risk of losing protective sensibility of the foot in patients with diabetes mellitus.

Authors:  Esther Chicharro-Luna; Francisco José Pomares-Gómez; Ana Belen Ortega-Ávila; Ana Marchena-Rodríguez; José Francisco Javier Blanquer-Gregori; Emmanuel Navarro-Flores
Journal:  Int Wound J       Date:  2019-11-05       Impact factor: 3.315

4.  Clinical and electrophysiological study of the peripheral nervous system in the elderly.

Authors:  P Bouche; F Cattelin; O Saint-Jean; J M Léger; S Queslati; D Guez; A Moulonguet; Y Brault; J P Aquino; P Simunek
Journal:  J Neurol       Date:  1993-05       Impact factor: 4.849

5.  Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population.

Authors:  Rok Seon Choung; G Richard Locke; Cathy D Schleck; Alan R Zinsmeister; L Joseph Melton; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2011-11-15       Impact factor: 10.864

Review 6.  Glucose control and diabetic neuropathy: lessons from recent large clinical trials.

Authors:  Lynn Ang; Mamta Jaiswal; Catherine Martin; Rodica Pop-Busui
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

7.  Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

Authors:  Catherine L Martin; James Albers; William H Herman; Patricia Cleary; Barbara Waberski; Douglas A Greene; Martin J Stevens; Eva L Feldman
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

Review 8.  Role of skin biopsy in the diagnosis of peripheral neuropathic pain.

Authors:  David Walk
Journal:  Curr Pain Headache Rep       Date:  2009-06

9.  Neurophysiological testing correlates with clinical examination according to fibre type involvement and severity in sensory neuropathy.

Authors:  J-P Lefaucheur; A Créange
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

10.  Subclinical nerve dysfunction in children and adolescents with IDDM.

Authors:  L Hyllienmark; T Brismar; J Ludvigsson
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.